An Open-Label Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderate to Severe Ulcerative Colitis.

Trial Profile

An Open-Label Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderate to Severe Ulcerative Colitis.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Aug 2016

At a glance

  • Drugs BL 7040 (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Sponsors BioLineRx
  • Most Recent Events

    • 29 Aug 2016 Results assessing efficacy,safety and tolerability published in the Digestive Diseases and Sciences (2016).
    • 26 Nov 2013 Additional results reported in a BioLineRx media release.
    • 17 Apr 2013 Status changed from active, no longer recruiting to completed, according to a BioLineRx media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top